Innovating Works

JANSSEN DI

Desconocido
ND4ID: New Diagnostics for Infectious Diseases ND4ID Infectious diseases are a major burden to public health and the global economy, not in the least due to antimicrobial resistance. Rapid poin...
2015-07-31 - 2020-02-29 | Financiado
CHAARM: Combined Highly Active Anti retroviral Microbicides JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7: This proposal is for a large scale collaborative project in which we propose both to develop novel microbicides directed against new intrace...
Financiado
THINC: TARGETING HIV INTEGRATION CO FACTORS TARGETING CELLULAR PROTEINS DURING NUCLEAR IMPORT OR INTEGRATI... JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7: Standard therapy of infection with the human immunodeficiency virus type 1 (HIV-1) is based on potent cocktails of drugs targeting viral pro...
Financiado
EUVIRNA: European Training Network on RNA Virus Replication and Antiviral Drug Development JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7: Virus infections remain a major cause of disease, with dramatic costs in mortality, morbidity, and economic loss worldwide. There is an unme...
Financiado
CHAIN: Collaborative HIV and Anti HIV Drug Resistance Network JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7: CHAIN is a large scale integrating project aimed to effectively and durably combat new and existing anti-HIV drug resistance in clinical set...
Financiado
PREPARE: Platform foR European Preparedness Against Re emerging Epidemics JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA participó en un FP7: Far from receding, the threats posed by infections with epidemic potential grow ever greater. Although Europe has amongst the best healthcar...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.